CRMD - CorMedix plans for stock and warrants offering size not disclosed
2023-06-28 16:32:45 ET
CorMedix ( NASDAQ: CRMD ) intends to conduct an underwritten public offering of common stock and pre-funded warrants, the company said Wednesday.
Shares -16.6% at $4.23 afterhours.
The company said it will be selling all of the shares and pre-funded warrants in the offering.
Pricing and details of the number of shares and pre-funded warrants to be offered were not disclosed.
The underwriters have a 30-day option to purchase up to an additional 15% of shares and pre-funded warrants.
RBC Capital Markets, Truist Securities, and JMP Securities are acting as book-running managers for the offering.
Net proceeds from the offering will be used for general corporate purposes, commercialization efforts, research and development, working capital, and general expenditures.
For further details see:
CorMedix plans for stock and warrants offering, size not disclosed